Skip to main content
. Author manuscript; available in PMC: 2014 May 8.
Published in final edited form as: Lancet Neurol. 2013 Mar 18;12(4):406–414. doi: 10.1016/S1474-4422(13)70011-5

Table 1.

Variable expressivity in selected microdeletion syndromes

Frequency in clinical cohorts* Intellectual disability or developmental delay Autism spectrum disorder Schizophrenia Epilepsy
22q11.2 1 in 167
16p11.2 1 in 241 ··
1q21.1 1 in 309
15q13.2-q13.3 1 in 358
7q11.23 1 in 415 ··
15q11.2-q13 1 in 553
17q21.31 1 in 700 ··
16p13.11 1 in 788
17q12 1 in 985
17p11.2 1 in 985 ··
8p23.1 1 in 1854 ··
5q35 1 in 1970 ··
3q29 1 in 2101 ··
*

Frequency in individuals referred for chromosomal microarray testing. Common indications for testing include neurodevelopmental disorders and multiple congenital anomalies.33